Dentistry and oral surgery - Plasma rich growth factors

When you get a splinter or receive a wound, the human body liberates a set of proteins (cellular signals) to stimulate the repair process for that wound.

The plasma rich in growth factors technique consists of isolating these proteins that are responsible for healing injuries and regenerating tissues from the blood plasma. Once applied in the area to be treated, and administered in a therapeutic dose, the repair process is optimised and accelerated naturally.

To prepare the plasma rich in growth factors and apply this procedure it is necessary to take a small amount of the patient's blood, from which “Plasma Rich in Growth Factors is obtained”, that is, a preparation containing a natural mixture of healing factors. This plasma is placed in the injured area to improve and accelerate healing.

This technique is currently being used with creditable results in different fields of medicine such as oral and maxillofacial surgery, arthroscopic surgery, orthopaedic surgery, cardiac surgery, plastic and reconstructive surgery, vascular medicine, dermatology, etc.

• Versatility: The versatility of the plasma rich in growth factors makes possible to create up to 4 different therapeutic formulations that adapt to the characteristics of each application.
• Small volumes of blood: The volume of blood used in plasma rich in growth factors is variable (from 9 ml) and adequate for each application. Obtaining its formulations is very efficient. Other systems use very large volumes of blood
• Just one centrifugation: Plasma rich in growth factors obtaining uses a simple protocol with a single centrifugation. Other technologies use a number of centrifugations that could cause premature platelet activation and even adverse effects.
• Therapeutic dose: The plasma rich in growth factors uses concentrations of growth factors within the therapeutic window to stimulate tissue regeneration. This fact has been demonstrated through in vitro investigation, experiments on animals and clinical trials. Other products use concentrations outside this window, obtaining unpredictable results.
• Autologous: Plasma rich in growth factors is the market's first autologous technology.
• Without pro-inflammatory effects: In addition, the plasma rich in growth factors enables leukocytes to be excluded from its formulation, thus avoiding their effects pro-inflammatory. This has been demonstrated in numerous scientific publications. In fact, its protein content has an anti-inflammatory effect once applied to the tissue.
• Without undesirable effects: In none of the treatments carried out in 15 years have any undesired effects been observed.

• Vanguardist technology technology with the most extensive experience in the market
• Biocompatible, versatile and safe.
• Bacteriostatic effect. That is, it does not contain the reproduction of bacteria.
• Great clinical efficiency in the stimulation of tissue healing and regeneration, as has been described in a large number of international articles.
• Decreased pain
• Decreased inflammation
• Plasma rich in growth factors is the only one that holds European (CE mark) and American (FDA Approval) health certifications, both for the different applications of the product and for each and every one of the elements necessary for their application (health products).
• A large number of therapeutic applications in diverse medical specialisations (traumatology, dermatology, etc.